Shandong Sanyuan Biotechnology Co.,Ltd.

SZSE:301206 Stock Report

Market Cap: CN¥5.6b

Shandong Sanyuan BiotechnologyLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shandong Sanyuan BiotechnologyLtd has a total shareholder equity of CN¥4.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥4.8B and CN¥239.7M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥216.80m
EquityCN¥4.53b
Total liabilitiesCN¥239.67m
Total assetsCN¥4.77b

Recent financial health updates

No updates

Recent updates

Investors Interested In Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) Earnings

Oct 06
Investors Interested In Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) Earnings

What You Can Learn From Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) P/S

Apr 06
What You Can Learn From Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) P/S

Financial Position Analysis

Short Term Liabilities: 301206's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥187.5M).

Long Term Liabilities: 301206's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥52.2M).


Debt to Equity History and Analysis

Debt Level: 301206 is debt free.

Reducing Debt: 301206 had no debt 5 years ago.

Debt Coverage: 301206 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301206 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies